Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
ChemMedChem · 2024-12-16 · 19 (24)
DOI: 10.1002/cmdc.202400549 ↗At a glance
Journal article in ChemMedChem, published on 2024-12-16. Written by Trent D Ashton and 23 co-authors. Institution: Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Victoria, Australia. Major MEDLINE topics: Antimalarials, Quinazolinones, Plasmodium falciparum. Cited 3 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council of Australia, Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS B.E.S., Medicines for Malaria Venture.
Abstract (original language)
The emergence of resistance against current antimalarial treatments has necessitated the need for the development of novel antimalarial chemotypes. Toward this goal, we recently optimised the antimalarial activity of the dihydroquinazolinone scaffold and showed it targeted PfATP4. Here, we deconstruct the lactam moiety of the tricyclic dihydroquinazolinone scaffold and investigate the structure‐activity relationship of the truncated scaffold. It was shown that SAR between scaffolds was largely transferrable and generated analogues with potent asexual stage activity. Evaluation of the truncated analogues against PfATP4 mutant drug‐resistant parasite strains and in assays measuring PfATP4‐associated ATPase activity demonstrated retention of PfATP4 as the molecular target. Analogues exhibited activity against both male and female gametes and multidrug resistant parasites. Limited efficacy of analogues in a P. berghei asexual stage mouse model was attributed to their moderate metabolic stability and low aqueous stability. Further development is required to address these attributes toward the potential use of the dihydroquinazolinone class in a curative and transmission blocking combination antimalarial therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Victoria, Australia.
- Department of Medical Biology, University of Melbourne, Parkville, 3010, Victoria, Australia.
- Research School of Biology, Australian National University, Canberra, 2601, Australia.
- TCG Lifesciences, Kolkata, West Bengal, 700091, India.
- Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
- Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, 5005, Australia.
ORCID profiles: Trent D Ashton, Petar P S Calic, Madeline G Dans, Katie Loi, Kate E Jarman, Deyun Qiu, Adele M Lehane, Mufuliat T Famodimu, Emma Y Mao, Maria R Gancheva, Danny W Wilson, Alan F Cowman, Brad E Sleebs
Funding
- National Health and Medical Research Council of Australia
- Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS B.E.S.
- Medicines for Malaria Venture
- Medical Research Council Career Development Award
- MMV grant
- Australian Red Cross Lifeblood
- Walter and Eliza Hall Institute
- Alan Harris Scholarship
Cite
APA
Ashton, T. D., Calic, P. P. S., Dans, M. G., Kang Ooi, Z., Zhou, Q., Loi, K., Jarman, K. E., Palandri, J., Qiu, D., Lehane, A. M., Maity, B., De, N., Famodimu, M. T., Delves, M. J., Mao, E. Y., Gancheva, M. R., Wilson, D. W., Chowdury, M., de Koning-Ward, T. F., …, & Sleebs, B. E. (2024). Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4. ChemMedChem. https://doi.org/10.1002/cmdc.202400549
Vancouver
Ashton TD, Calic PPS, Dans MG, Kang Ooi Z, Zhou Q, Loi K, et al. Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4. ChemMedChem. 2024. doi:10.1002/cmdc.202400549
BibTeX
@article{Ashton2024,
author = {Ashton, Trent D and Calic, Petar P S and Dans, Madeline G and Kang Ooi, Zi and Zhou, Qingmiao and Loi, Katie and Jarman, Kate E and Palandri, Josephine and Qiu, Deyun and Lehane, Adele M and Maity, Bikash and De, Nirupam and Famodimu, Mufuliat T and Delves, Michael J and Mao, Emma Y and Gancheva, Maria R and Wilson, Danny W and Chowdury, Mrittika and de Koning-Ward, Tania F and Baud, Delphine and Brand, Stephen and Jackson, Paul F and Cowman, Alan F and Sleebs, Brad E},
title = {Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400549}
}
EUVIMED